Charles River Laboratories Intl. Inc vs DuPont de Nemours Inc — how do they compare? Charles River Laboratories Intl. Inc trades at $287.99 (market cap $13.46B), while DuPont de Nemours Inc trades at $144.26 (market cap $19.51B). The key difference: DuPont de Nemours Inc is the larger of the two by market cap, and DuPont de Nemours Inc pays a 1.66% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.
| CRL | DD | |
|---|---|---|
Market Cap | $13.46B | $19.51B |
Sector | Health | Basic Materials |
52-Week High | $282.00 | $154.59 |
52-Week Low | $145.57 | $90.24 |
Enterprise Value | $16.30B | $20.90B |
Dividend Yield | — | 1.66% |
Trailing returns across standard periods
Latest headlines on both assets
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics and communication, automotive, construction, safety and protection, and water management industries. DuPont benefits from the ability to produce patented specialty chemicals that command pricing power. Noteworthy products include Kevlar, Tyvek, and Nomex have evolved over time to enable a wide range of applications across multiple industries.
Read more on DD →